The immunomodulatory phenomenon of vitamin D in the pathogenesis of Multiple Sclerosis
DOI:
https://doi.org/10.12775/JEHS.2023.14.01.004Keywords
vitamin D, multiple sclerosis, nervous systemAbstract
People living in areas with limited access to sunlight, do not produce enough vitamin D and are more likely to suffer from Multiple Sclerosis.Near the equator, where there is high exposure to the sun, the disease is almost non-existent.
Aim of the study: The study aimto statistical data on the literature and presents the current state of Vitamin D deficiency as a risk factor in multiple sclerosis.
Material and method: The method of study is descriptive epidemiological analysis. Information that has been used is derived from statistical data provided by the WHO. In searching for them on the WHO, PubMed website, Google Scholar, and SCOPUS.
Results and conclusions: Vitamin D is a regulator of calcium and phosphorus levels and affects the development and proper functioning of the nervous system. Patients with Multiple sclerosis often have low serum vitamin D levels, which tend to decrease as the disease progresses. There are theories that a deficiency of this vitamin promotes autoimmune, inflammatory demyelination.
References
Gombash SE, Lee PW, Sawdai E, Lovett-Racke AE. Vitamin D as a Risk Factor for Multiple Sclerosis: Immunoregulatory or Neuroprotective? Front Neurol. 2022 May 16;13:796933. Doi: 10.3389/fneur.2022.796933. PMID: 35651353; PMCID: PMC9149265.
Witamina D a stwardnienie rozsiane – Polskie Towarzystwo Stwardnienia Rozsianego (ptsrkonskie.org.pl).
Vasileiou ES, Hu C, Bernstein CN, Lublin F, Wolinsky JS, Cutter GR, Sotirchos ES, Kowalec K, Salter A, Saidha S, Mowry EM, Calabresi PA, Marrie RA, Fitzgerald KC. Association of Vitamin D Polygenic Risk Scores and Disease Outcome in People With Multiple Sclerosis. NeurolNeuroimmunolNeuroinflamm. 2022 Nov 23;10(1):e200062. Doi: 10.1212/NXI.0000000000200062. PMID: 36418179; PMCID: PMC9747144.
Galus W, Walawska-Hrycek A, Rzepka M, Krzystanek E. Vitamin D Supplementation Practices among Multiple Sclerosis Patients and Professionals. J Clin Med. 2022 Dec 8;11(24):7278. Doi: 10.3390/jcm11247278. PMID: 36555896; PMCID: PMC9787609.
https://pl.wikipedia.org/wiki/Stwardnienie_rozsiane.
Vandebergh M, Degryse N, Dubois B, Goris A. Environmental risk factors in multiple sclerosis: bridging Mendelian randomization and observational studies. J Neurol. 2022 Aug;269(8):4565-4574. Doi: 10.1007/s00415-022-11072-4. Epub 2022 Apr 2. PMID: 35366084.
Elkama A, Orhan G, Karahalil B. Association of vitamin D receptor polymorphisms with vitamin D and calcium levels in Turkish multiple sclerosis patients. Neurodegener Dis Manag. 2022 Dec;12(6):323-331. doi: 10.2217/nmt-2022-0005. Epub 2022 Jul 18. PMID: 35848285.
Fatima M, Lamis A, Siddiqui SW, Ashok T, Patni N, Fadiora OE. Therapeutic Role of Vitamin D in Multiple Sclerosis: An Essentially Contested Concept. Cureus. 2022 Jun 22;14(6):e26186. doi: 10.7759/cureus.26186. PMID: 35911285; PMCID: PMC9311493.
Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ascherio A, Munger KL. Ann Neurol. 2007;61:288–299.
Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors. Ascherio A, Munger KL. Ann Neurol. 2007;61:504–513.
Vitamin D: a candidate for the environmental effect in multiple sclerosis - observations from Norway. Kampman MT, Brustad M. Neuroepidemiology. 2008;30:140–146.
Vitamin D intake and incidence of multiple sclerosis. Munger KL, Zhang SM, O'Reilly E, Hernán MA, Olek MJ, Willett WC, Ascherio A. Neurology. 2004;62:60–65.
Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A. JAMA. 2006;296:2832–2838.
Zhang Y, Liu H, Zhang H, Han Z, Wang T, Wang L, Liu G. Causal association of genetically determined circulating vitamin D metabolites and calcium with multiple sclerosis in participants of European descent. Eur J Clin Nutr. 2023 Jan 12. doi: 10.1038/s41430-023-01260-4. Epub ahead of print. PMID: 36635366.
Bivona G, Scazzone C, Sasso BL, Giglio RV, Gambino CM, Agnello L, Ciaccio M. Multiple Sclerosis Pathogenesis: Possible Interplay between Vitamin D Status and Epstein Barr Virus Infection. J IntegrNeurosci. 2023 Jan 4;22(1):7. doi: 10.31083/j.jin2201007. PMID: 36722238.
Sharif K, Sharif Y, Watad A, Yavne Y, Lichtbroun B, Bragazzi NL, et al. Vitamin D, autoimmunity and recurrent pregnancy loss: More than an association. American Journal of Reproductive Immunology. 2018; 80: e12991.
Ali A, Cui X, Eyles D. Developmental vitamin D deficiency and autism: Putative pathogenic mechanisms. The Journal of Steroid Biochemistry and Molecular Biology. 2018; 175: 108–118.
Scazzone C, Agnello L, Sasso BL, Ragonese P, Bivona G, Realmuto S, et al. Klotho and vitamin D in multiple sclerosis: an Italian study. Archives of Medical Science. 2019; 16: 842–847.
Plantone D, Primiano G, Manco C, Locci S, Servidei S, De Stefano N. Vitamin D in Neurological Diseases. Int J Mol Sci. 2022 Dec 21;24(1):87. doi: 10.3390/ijms24010087. PMID: 36613531; PMCID: PMC9820561.
Brownlee W.J., Hardy T.A., Fazekas F., Miller D.H. Diagnosis of Multiple Sclerosis: Progress and Challenges. Lancet. 2017;389:1336–1346. doi: 10.1016/S0140-6736(16)30959-X. [PubMed] [CrossRef] [Google Scholar] [Ref list].
Lublin F.D., Reingold S.C., Cohen J.A., Cutter G.R., Sørensen P.S., Thompson A.J., Wolinsky J.S., Balcer L.J., Banwell B., Barkhof F., et al. Defining the Clinical Course of Multiple Sclerosis: The 2013 Revisions. Neurology. 2014;83:278–286. doi: 10.1212/WNL.0000000000000560. [PMC free article] [PubMed] [CrossRef] [Google Scholar] [Ref list].
Miller D.H., Leary S.M. Primary-Progressive Multiple Sclerosis. Lancet Neurol. 2007;6:903–912. doi: 10.1016/S1474-4422(07)70243-0. [PubMed] [CrossRef] [Google Scholar] [Ref list]
Plantone D, Primiano G, Manco C, Locci S, Servidei S, De Stefano N. Vitamin D in Neurological Diseases. Int J Mol Sci. 2022 Dec 21;24(1):87. doi: 10.3390/ijms24010087. PMID: 36613531; PMCID: PMC9820561.
Ascherio A. Environmental Factors in Multiple Sclerosis. Expert Rev. Neurother. 2013;13:3–9. doi: 10.1586/14737175.2013.865866. [PubMed] [CrossRef] [Google Scholar] [Ref list].
Vukusic S., van Bockstael V., Gosselin S., Confavreux C. Regional Variations in the Prevalence of Multiple Sclerosis in French Farmers. J. Neurol. Neurosurg. Psychiatry. 2007;78:707–709. doi: 10.1136/jnnp.2006.101196. [PMC free article] [PubMed] [CrossRef] [Google Scholar] [Ref list]
Hammond S.R., Mcleod J.G., Millingen K.S., Stewart-wynne E.G., English D., Holland J.T., Mccall M.G. The Epidemiology of Multiple Sclerosis in Three Australian Cities: Perth, Newcastle and Hobart. Brain. 1988;111:1–25. doi: 10.1093/brain/111.1.1. [PubMed] [CrossRef] [Google Scholar] [Ref list].
Miller D.H., Purdie G., Hammond S.R., McLeod J.G., Skegg D.C.G. Multiple Sclerosis in Australia and New Zealand: Are the Determinants Genetic or Environmental? J. Neurol. Neurosurg. Psychiatry. 1990;53:903–905. doi: 10.1136/jnnp.53.10.903. [PMC free article] [PubMed] [CrossRef] [Google Scholar] [Ref list].
Rabenberg M., Scheidt-Nave C., Busch M.A., Thamm M., Rieckmann N., Durazo-Arvizu R.A., Dowling K.G., Škrabáková Z., Cashman K.D., Sempos C.T., et al. Implications of Standardization of Serum 25-Hydroxyvitamin D Data for the Evaluation of Vitamin D Status in Germany, Including a Temporal Analysis. BMC Public Health. 2018;18:845. doi: 10.1186/s12889-018-5769-y. - DOI - PMC – PubMed
Pilz S., März W., Cashman K.D., Kiely M.E., Whiting S.J., Holick M.F., Grant W.B., Pludowski P., Hiligsmann M., Trummer C., et al. Rationale and Plan for Vitamin D Food Fortification: A Review and Guidance Paper. Front. Endocrinol. 2018;9:373. doi: 10.3389/fendo.2018.00373. - DOI - PMC – PubMed
Grossman D.C., Curry S.J., Owens D.K., Barry M.J., Caughey A.B., Davidson K.W., Doubeni C.A., Epling J.W., Kemper A.R., Krist A.H., et al. Vitamin D, Calcium, OR Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults Us Preventive Services Task Force Recommendation Statement. JAMA. 2018;319:1592–1599. doi: 10.1001/jama.2018.3185. - DOI – PubMed
Jääskeläinen T., Itkonen S.T., Lundqvist A., Erkkola M., Koskela T., Lakkala K., Dowling K.G., Hull G.L.J., Kröger H., Karppinen J., et al. The Positive Impact of General Vitamin D Food Fortification Policy on Vitamin D Status in a Representative Adult Finnish Population: Evidence from an 11-y Follow-up Based on Standardized 25-HydroxyVitamin D Data. Am. J. Clin. Nutr. 2017;105:1512–1520. doi: 10.3945/ajcn.116.151415. - DOI – PubMed
Wilson L.R., Tripkovic L., Hart K.H., Lanham-New S.A. Vitamin D Deficiency as a Public Health Issue: Using Vitamin D2 or Vitamin D3 in Future Fortification Strategies. Proc. Nutr. Soc. 2017;76:392–399. doi: 10.1017/S0029665117000349. - DOI – PubMed
Sales N.M.R., Pelegrini P.B., Goersch M.C. Nutrigenomics: Definitions and Advances of This New Science. J. Nutr. Metab. 2014;2014:202759. doi: 10.1155/2014/202759. - DOI - PMC – PubMed
Pike J.W. Genome-wide Principles of Gene Regulation by the Vitamin D Receptor and Its Activating Ligand. Mol. Cell Endocrinol. 2011;347:3–10. doi: 10.1016/j.mce.2011.05.012. - DOI - PMC – PubMed
Carlberg C., Molnár F. Vitamin D Receptor Signaling and Its Therapeutic Implications: Genome-Wide and Structural View. Can. J. Physiol. Pharmacol. 2015;93:311–318. doi: 10.1139/cjpp-2014-0383. - DOI - PubMed
Nandi S., Blais A., Ioshikhes I. Identification of cis-regulatory modules in promoters of human genes exploiting mutual positioning of transcription factors. Nucleic Acids Res. 2013;41:8822–8841. doi: 10.1093/nar/gkt578. - DOI - PMC - PubMed
Pike J.W., Christakos S. Biology and Mechanisms of Action of the Vitamin D Hormone. Endocrinol. Metab. Clin. N. Am. 2017;46:815–843. doi: 10.1016/j.ecl.2017.07.001. - DOI - PMC – PubMed
Wei Z., Yoshihara E., He N., Hah N., Fan W., Pinto A.F.M., Huddy T., Wang Y., Ross B., Estepa G., et al. Vitamin D Switches BAF Complexes to Protect β Cells. Cell. 2018;173:1135–1149. doi: 10.1016/j.cell.2018.04.013. - DOI - PMC - PubMed
Prietl B., Treiber G., Pieber T.R., Amrein K. Vitamin D and Immune Function. Nutrients. 2013;5:2502–2521. doi: 10.3390/nu5072502. - DOI - PMC - PubMed
von Essen M.R., Kongsbak M., Schjerling P., Olgaard K., Ødum N., Geisler C. Vitamin D Controls T Cell Antigen Receptor Signaling and Activation of Human T Cells. Nat. Immunol. 2010;11:344–349. doi: 10.1038/ni.1851. - DOI – PubMed
Walton C, King R, Rechtman L, Kaye W, Leray E, Marrie RA, et al. . Rising prevalence of multiple sclerosis worldwide: Insights from the atlas of MS, third edition. Mult Scler. (2020) 26:1816–21. 10.1177/1352458520970841 - DOI - PMC – PubMed
Bhatia S., Rawal R., Sharma P., Singh T., Singh M., Singh V. Mitochondrial Dysfunction in Alzheimer’s Disease: Opportunities for Drug Development. Curr. Neuropharmacol. 2021;20:675–692. doi: 10.2174/18756190MTE1dNjU60. - DOI - PubMed
Halliday G., Robinson S.R., Shepherd C., Kril J. Alzheimer’s Disease and Inflammation: A Review of Cellular and Therapeutic Mechanisms. Clin. Exp. Pharmacol. Physiol. 2000;27:1–8. doi: 10.1046/j.1440-1681.2000.03200.x. - DOI – PubMed
Etgen T., Sander D., Bickel H., Sander K., Förstl H. Vitamin D Deficiency, Cognitive Impairment and Dementia: A Systematic Review and Meta-Analysis. Dement. Geriatr. Cogn. Disord. 2012;33:297–305. doi: 10.1159/000339702. - DOI - PubMed
Knekt P., Sääksjärvi K., Järvinen R., Marniemi J., Männistö S., Kanerva N., Heliövaara M. Serum 25-Hydroxyvitamin D Concentration and Risk of Dementia. Epidemiology. 2014;25:799–804. doi: 10.1097/EDE.0000000000000175. - DOI – PubMed
Jia J., Hu J., Huo X., Miao R., Zhang Y., Ma F. Effects of Vitamin D Supplementation on Cognitive Function and Blood Aβ-Related Biomarkers in Older Adults with Alzheimer’s Disease: A Randomised, Double-Blind, Placebo-Controlled Trial. J. Neurol. Neurosurg. Psychiatry. 2019;90:1347–1352. doi: 10.1136/jnnp-2018-320199. - DOI - PubMed
Yang T., Wang H., Xiong Y., Chen C., Duan K., Jia J., Ma F. Vitamin D Supplementation Improves Cognitive Function through Reducing Oxidative Stress Regulated by Telomere Length in Older Adults with Mild Cognitive Impairment: A 12-Month Randomized Controlled Trial. J. Alzheimers Dis. 2020;78:1509–1518. doi: 10.3233/JAD-200926. - DOI - PubMed
Lai R.H., Hsu C.C., Yu B.H., Lo Y.R., Hsu Y.Y., Chen M.H., Juang J.L. Vitamin D supplementation worsens Alzheimer’s progression: Animal model and human cohort studies. Aging Cell. 2022;21:e13670. doi: 10.1111/acel.13670. - DOI - PMC – PubMed
Luthra N.S., Kim S., Zhang Y., Christine C.W. Characterization of Vitamin D Supplementation and Clinical Outcomes in a Large Cohort of Early Parkinson’s Disease. J. Clin. Mov. Disord. 2018;5:7. doi: 10.1186/s40734-018-0074-6. - DOI - PMC - PubMed
Masrori P., van Damme P. Amyotrophic Lateral Sclerosis: A Clinical Review. Eur. J. Neurol. 2020;27:1918–1929. doi: 10.1111/ene.14393. - DOI - PMC - PubMed
Hardiman O., Al-Chalabi A., Chio A., Corr E.M., Logroscino G., Robberecht W., Shaw P.J., Simmons 51.Z., van den Berg L.H. Amyotrophic Lateral Sclerosis. Nat. Rev. Dis. Prim. 2017;3:17071. doi: 10.1038/nrdp.2017.71. - DOI - PubMed
Lanznaster D., Bejan-Angoulvant T., Gandía J., Blasco H., Corcia P. Is There a Role for Vitamin D in Amyotrophic Lateral Sclerosis? A Systematic Review and Meta-Analysis. Front. Neurol. 2020;11:697. doi: 10.3389/fneur.2020.00697. - DOI - PMC – PubMed
Smolders J., Menheere P., Kessels A., Damoiseaux J., Hupperts R. Association of Vitamin D Metabolite Levels with Relapse Rate and Disability in Multiple Sclerosis. Mult. Scler. 2008;14:1220–1224. doi: 10.1177/1352458508094399. - DOI - PubMed
Zhang Y., Liu G., Han X., Dong H., Geng J. The Association of Serum 25-Hydroxyvitamin D Levels with Multiple Sclerosis Severity and Progression in a Case-Control Study from China. J. Neuroimmunol. 2016;297:127–131. doi: 10.1016/j.jneuroim.2016.05.022. - DOI - PubMed
Mandia D., Ferraro O.E., Nosari G., Montomoli C., Zardini E., Bergamaschi R. Environmental Factors and Multiple Sclerosis Severity: A Descriptive Study. Int. J. Environ. Res. Public Health. 2014;11:6417–6432. doi: 10.3390/ijerph110606417. - DOI - PMC - PubMed
Ascherio A., Munger K.L., White R., Köchert K., Simon K.C., Polman C.H., Freedman M.S., Hartung H.P., Miller D.H., Montalbán X., et al. Vitamin D as an Early Predictor of Multiple Sclerosis Activity and Progression. JAMA Neurol. 2014;71:306–314. doi: 10.1001/jamaneurol.2013.5993. - DOI - PMC – PubMed
Harroud A., Manousaki D., Butler-Laporte G., Mitchell R.E., Davey Smith G., Richards J.B., Baranzini S.E. The relative contributions of obesity, vitamin D, leptin, and adiponectin to multiple sclerosis risk: A Mendelian randomization mediation analysis. Mult. Scler. 2021;27:1994–2000. doi: 10.1177/1352458521995484. - DOI - PubMed
Vandebergh M., Dubois B., Goris A. Effects of Vitamin D and Body Mass Index on Disease Risk and Relapse Hazard in Multiple Sclerosis: A Mendelian Randomization Study. Neurol. Neuroimmunol. Neuroinflamm. 2022;9:e1165. doi: 10.1212/NXI.0000000000001165. - DOI - PMC – PubMed
O’Connell K., Sulaimani J., Basdeo S.A., Kinsella K., Jordan S., Kenny O., Kelly S.B., Murphy D., Heffernan E., Killeen R.P., et al. Effects of Vitamin D3 in Clinically Isolated Syndrome and Healthy Control Participants: A Double-Blind Randomised Controlled Trial. Mult. Scler. J. Exp. Transl. Clin. 2017;3:2055217317727296. doi: 10.1177/2055217317727296. - DOI - PMC - PubMed
Hupperts R., Smolders J., Vieth R., Holmøy T., Marhardt K., Schluep M., Killestein J., Barkhof F., Beelke M., Grimaldi L.M.E. Randomized Trial of Daily High-Dose Vitamin D3 in Patients with RRMS Receiving Subcutaneous Interferon β-1a. Neurology. 2019;93:e1906. doi: 10.1212/WNL.0000000000008445. - DOI - PMC - PubMed
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Karolina Raksa, Mateusz Pawlina, Karolina Ziętara, Aleksander Oskroba, Aleksandra Orzechowska, Natalia Pawełczak, Bartłomiej Zielonka, Ilona Kowalczyk, Piotr Pawłowski, Cezary Stawikowski
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 483
Number of citations: 0
